CEO Yu-Hsin Lin highlighted the company's "most significant achievement" with the Phase III DRAGON trial meeting its primary efficacy endpoint, reporting a "36% reduction in the growth rate of upper ...
As announced, Jaguar received an up-front payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi and Canalevia-CA1 - Jaguar's two comme ...
The Spanish government said in a statement that the bases must “operate within the framework of international law.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results